Intrapericardial NUT Midline Carcinoma

Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations

Stefani Samples, Katrina Gleditsch, Anastasios Charalanpos Polimenakos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.

Original languageEnglish (US)
Pages (from-to)208-211
Number of pages4
JournalPediatric Cardiology
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Nuclear Proteins
Testis
Carcinoma
Neoplasms
Therapeutics
Radiotherapy
Drug Therapy
Genes

Keywords

  • Carcinoma
  • Cardiac tumor
  • Malignancy
  • Surgical resection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Intrapericardial NUT Midline Carcinoma : Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations. / Samples, Stefani; Gleditsch, Katrina; Polimenakos, Anastasios Charalanpos.

In: Pediatric Cardiology, Vol. 37, No. 1, 01.01.2016, p. 208-211.

Research output: Contribution to journalArticle

@article{15b42cf6af044a5fbe743951ee691e0c,
title = "Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations",
abstract = "Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.",
keywords = "Carcinoma, Cardiac tumor, Malignancy, Surgical resection",
author = "Stefani Samples and Katrina Gleditsch and Polimenakos, {Anastasios Charalanpos}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/s00246-015-1313-3",
language = "English (US)",
volume = "37",
pages = "208--211",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Intrapericardial NUT Midline Carcinoma

T2 - Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations

AU - Samples, Stefani

AU - Gleditsch, Katrina

AU - Polimenakos, Anastasios Charalanpos

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.

AB - Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.

KW - Carcinoma

KW - Cardiac tumor

KW - Malignancy

KW - Surgical resection

UR - http://www.scopus.com/inward/record.url?scp=84957438200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957438200&partnerID=8YFLogxK

U2 - 10.1007/s00246-015-1313-3

DO - 10.1007/s00246-015-1313-3

M3 - Article

VL - 37

SP - 208

EP - 211

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 1

ER -